Parallax Volatility Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-56,500
Closed -$10M 2984
2020
Q1
$10M Sell
56,500
-3,500
-6% -$659K 0.01% 615
2019
Q4
$11.5M Buy
60,000
+26,400
+79% +$4.76M 0.01% 604
2019
Q3
$5.66M Buy
33,600
+11,500
+52% +$1.87M 0.01% 773
2019
Q2
$3.7M Buy
22,100
+2,700
+14% +$374K ﹤0.01% 837
2019
Q1
$2.84M Sell
19,400
-48,400
-71% -$7.02M ﹤0.01% 873
2018
Q4
$9.06M Sell
67,800
-51,600
-43% -$8.46M 0.01% 540
2018
Q3
$22.7M Buy
119,400
+32,400
+37% +$5.95M 0.03% 262
2018
Q2
$14.5M Buy
87,000
+12,000
+16% +$1.93M 0.02% 345
2018
Q1
$12.6M Sell
75,000
-13,000
-15% -$2.18M 0.02% 334
2017
Q4
$14.4M Sell
88,000
-14,400
-14% -$2.58M 0.02% 324
2017
Q3
$21M Buy
102,400
+39,700
+63% +$9.23M 0.03% 255
2017
Q2
$15.2M Sell
62,700
-3,500
-5% -$822K 0.03% 309
2017
Q1
$15.8M Sell
66,200
-5,635,400
-99% -$1.31B 0.03% 289
2016
Q4
$1.2B Buy
5,701,600
+5,696,600
+113,932% +$1.18B 2.34% 7
2016
Q3
$1.15M Buy
+5,000
New +$1.22M ﹤0.01% 1209
2016
Q1
Sell
-31,400
Closed -$9.81M 4087
2015
Q4
$9.81M Sell
31,400
-23,700
-43% -$7.06M 0.02% 464
2015
Q3
$15M Buy
+55,100
New +$16.9M 0.03% 318

Other funds holding AGN

Parallax Volatility Advisers's AGN Position: Q2 2020 in Review

Parallax Volatility Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 40,564 shares — an estimated $7.18M sold.

Parallax Volatility Advisers first reported a position in AGN in Q4 2013 and held it in 13 quarters. The position peaked at $8.73M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Parallax Volatility Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 40,564 Allergan plc shares in Q2 2020, an estimated $7.18M.
  • Parallax Volatility Advisers first reported a position in Allergan plc in Q4 2013 and held it in 13 quarters.
  • Parallax Volatility Advisers's Allergan plc position peaked at $8.73M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Parallax Volatility Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.